UPDATED Mar 27, 2024
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BIX0 | kr1.44 | 1.8% | -40.9% | kr1.1b | kr9.29 | PS15.5x | E60.1% | n/a | ||
IDD | €2.14 | 2.4% | -16.9% | €177.0m | €6.11 | PS2.9x | E29.8% | n/a | ||
08D | US$23.00 | -4.2% | 9.5% | US$1.2b | US$44.86 | PS6.3x | E63.2% | n/a | ||
P0F | kr0.56 | 3.7% | 28.3% | kr1.9b | kr1.12 | PS33.5x | E85.4% | n/a | ||
OL0 | kr8.64 | 1.9% | 37.6% | kr1.6b | kr9.87 | PS9.7x | E99.3% | n/a | ||
51KA | US$14.60 | 0% | 18.7% | US$425.1m | US$23.44 | PS8.5x | E64.0% | n/a | ||
41X | US$6.80 | -4.2% | 60.3% | US$1.7b | US$12.22 | PS13.9x | E60.6% | n/a | ||
IMU | US$28.74 | 6.8% | 615.5% | US$8.4b | US$26.83 | PS29.1x | E45.9% | n/a | ||
IDDA | €2.16 | -0.9% | -14.3% | €177.0m | €6.18 | PS2.9x | E29.8% | n/a | ||
3EE0 | kr0.16 | 15.9% | -46.1% | kr139.7m | n/a | PB2.9x | E131.9% | n/a | ||
9II | kr0.20 | 17.5% | -72.2% | kr208.0m | kr1.23 | PS29.9x | E83.0% | n/a | ||
7UX | kr0.022 | -8.4% | -66.5% | kr65.2m | n/a | PS11x | E56.0% | n/a | ||
G1H | US$3.91 | 31.6% | 62.9% | US$233.3m | US$7.44 | PS2.8x | E55.1% | n/a | ||
51KB | US$2.90 | 1.4% | 20.3% | US$425.1m | US$4.65 | PS8.5x | E64.0% | n/a | ||
0S90 | US$5.66 | 1.1% | 132.0% | US$151.9m | US$18.66 | PS15.3x | E59.1% | n/a | ||
P0F | kr0.44 | 0% | n/a | kr1.9b | n/a | PS33.5x | E85.4% | n/a | ||
8XX | €1.42 | 3.6% | -36.9% | €31.3m | n/a | PS344x | E97.2% | n/a | ||
DR6 | US$16.30 | -4.1% | -3.9% | US$3.0b | US$26.25 | PS4.1x | E41.9% | n/a | ||
AB3A | US$118.15 | 3.9% | -4.4% | US$12.2b | US$149.08 | PS9.8x | E41.9% | n/a | ||
YP1A | AU$2.20 | 1.9% | 47.7% | AU$439.9m | AU$7.71 | PS111.9x | E62.1% | n/a | ||
328 | US$5.60 | -1.8% | 25.6% | US$398.8m | US$19.48 | PS28.5x | E52.8% | n/a | ||
1RV | US$36.80 | 4.0% | 132.9% | US$2.5b | US$50.39 | PS32.5x | E61.1% | n/a | ||
2CX | US$51.89 | -0.9% | 79.0% | US$3.7b | US$51.90 | PS100.3x | E69.1% | n/a | ||
NB11 | US$3.81 | 0% | -36.9% | US$541.2m | US$10.15 | PS1150.5x | E76.0% | n/a |